DX-DRG-R02

N/A

Report date: 2026/05/12 09:17:12

Base Information

Drug NameDX-DRG-R02

Drug Alias NameDX-DRG-R02

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDx&Vx Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDx&Vx Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A